In DYT1 dystonia, caused by a TOR1A mutation, torsinB levels influence disease severity. In DYT1 mouse models, lowering torsinB worsens movements and neurodegeneration, while raising it rescues these deficits, suggesting torsinB augmentation could delay symptoms.